Delays in UK child brain tumor diagnosis

Aug 07, 2009

Significant numbers of children in the UK are suffering from preventable levels of disability, particularly blindness, and premature death because of poor diagnosis of brain tumours.

A new study by scientists at The University of Nottingham's Children's Tumour Research Centre, funded by the Samantha Dickson Trust, shows that prolonged and slow can make long term survivors of childhood brain tumours up to 10 times more likely to suffer disability. 450 children in the UK are diagnosed with a brain tumour every year. The average time between the onset of symptoms and diagnosis in children in the UK is between two and three months, that's up to three times longer than the rest of Europe and the USA.

David Walker, Professor of Paediatric Oncology at the Children's Brain Tumour Research Centre, University of Nottingham, said: "Our study showed that the UK health system is the slowest system for making this diagnosis compared to reports from other countries. It takes more than 13 weeks in the UK to make this diagnosis for half of the patients, whilst in the US and Poland this is achieved within 5 weeks. The research also showed that symptoms increased in number and that disability increased in severity as time passed before diagnosis. This indicates that delays in diagnosis are affecting the severity of disability for the children and young people, which can have life-long consequences. "

Chief Executive of the Samantha Dickson Brain Tumour Trust, Paul Carbury said: "A quarter of all childhood cancers now occur in the brain and more children are dying of brain tumours than any other cancer. We are concerned that children in the UK are being short-changed by delays in diagnosis, which are leading to poor outcomes compared with the rest of Europe and the USA. This is true for teenagers too, with evidence suggesting that many visit their GP numerous times before being referred."

David Kershaw, who lost his two year old son, Jake, to a brain tumour, is angry about the slow diagnosis they suffered. He said: "There is still so much ignorance regarding the diagnosis of brain tumours. I had to fight extremely hard to be taken seriously when Jake became unwell. It is very clear to me that more work needs to be done within the medical profession to hasten diagnosis, which will improve the long term outcome for other children."

Brain cancer has the highest fatality rate of all childhood cancers. Research into the disease receives a fraction of the funding of higher profile cancers, The Children's Brain Tumour Research Centre at The University of Nottingham was initiated as a result of expression of public and professional concern that the needs of children being diagnosed and managed with brain and spinal tumours was a gap in research and clinical development, linking paediatric neuroscience, clinical practice in paediatric and health service strategy. The centre, initiated by public donations of £1.8m raised between 1997 and 2007, has provide a clinical academic focus to bring basic science, clinical academic researchers to apply their expertise to the needs of with brain and spinal tumours.

Source: University of Nottingham (news : web)

Explore further: Novel regulator of a protein inactive in over 50 percent of human tumors

add to favorites email to friend print save as pdf

Related Stories

Scientists identify childhood brain cancer genes

Sep 15, 2008

Scientists at The University of Nottingham have isolated three important genes involved in the development of a type of childhood brain cancer. The breakthrough is revealed in a study published in the British Journal of Ca ...

Study finds biological clue in brain tumour development

Mar 18, 2009

(PhysOrg.com) -- Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for a children's brain tumour that currently kills more than 60 per cent ...

Can children have strokes?

Jul 01, 2008

Childhood stroke is at least as common as brain tumours in children and may be as common as all childhood cancer but the condition is under-recognised by both the public and the medical profession. A new study hopes to address ...

Recommended for you

Lanreotide improves survival with enteropancreatic tumors

15 hours ago

(HealthDay)—Lanreotide significantly improves survival among patients with metastatic enteropancreatic neuroendocrine tumors (grade 1 or 2), according to a study published in the July 17 issue of the New En ...

User comments : 0